White House Fast-Tracks Psychedelic Mental Health Therapies
FDA review for psychedelic therapies fast-tracked by executive order. Expands research, patient access for mental health, and prepares for drug rescheduling.
04 May 2026
FDA review for psychedelic therapies fast-tracked by executive order. Expands research, patient access for mental health, and prepares for drug rescheduling.
Trump order accelerates psychedelic research, including $50 million for ibogaine studies, with veterans’ mental health highlighted on April 18.
